MEDS in America Act

Hozzl · 2022-12-30T08:18:24Z

Explore the details of House Bill 5993 MEDS in America Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Commerce. Stay informed on legislative developments.

12/30/2022, 8:18 AM

Summary of Bill HR 5993

The MEDS in America Act, also known as Bill 117 hr 5993, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to address the rising costs of prescription medications in the United States.

One key provision of the MEDS in America Act is the establishment of a Prescription Drug Affordability Board. This board would be responsible for setting limits on the prices of certain prescription drugs in order to make them more affordable for consumers. The board would also have the authority to negotiate prices with drug manufacturers in order to lower costs.

Another important aspect of the bill is the creation of a Prescription Drug Affordability Fund. This fund would provide financial assistance to individuals who are struggling to afford their prescription medications. The fund would be funded through a combination of government appropriations and contributions from drug manufacturers. Additionally, the MEDS in America Act includes measures to increase transparency in the pharmaceutical industry. Drug manufacturers would be required to disclose information about the costs of producing their medications, as well as any financial assistance programs they offer to consumers. Overall, the MEDS in America Act aims to address the issue of rising prescription drug costs in the United States through a combination of price controls, financial assistance programs, and increased transparency in the pharmaceutical industry. It is currently being debated in Congress, and its ultimate fate remains uncertain.

Congressional Summary of HR 5993

Making Essential Drugs in America Act or the MEDS in America Act

This bill requires the Food and Drug Administration to provide grants for institutions to establish centers for recruiting and training biopharmaceutical manufacturing workers. Eligible institutions include institutions of higher education and entities conducting registered apprenticeship programs.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5993

Bill HR 5993 is currently in the status of Bill Introduced since November 17, 2021. Bill HR 5993 was introduced during Congress 117 and was introduced to the House on November 17, 2021. Bill HR 5993's most recent activity was Referred to the Subcommittee on Health. as of November 18, 2021

Bipartisan Support of Bill HR 5993

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5993

Primary Policy Focus

Commerce

Alternate Title(s) of Bill HR 5993

MEDS in America ActMEDS in America ActMaking Essential Drugs in America ActTo direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to establish a competitive grant program under which the Secretary will award grants to certain institutions to establish American Biopharmaceutical Manufacturing Worker Training Centers of Excellence, and for other purposes.

Start holding our government accountable!

Comments

Sponsors and Cosponsors of HR 5993

G. K. Butterfield

North Carolina(Democrat)

Latest Bills

Authorizing the use of the Capitol Grounds for the National Peace Officers Memorial Service and the National Honor Guard and Pipe Band Exhibition.

Bill HCONRES 9April 12, 2025